145 related articles for article (PubMed ID: 27084210)
1. New clinical insights into combined central and peripheral demyelination (CCPD).
Kamm C
J Neurol Sci; 2016 May; 364():27-8. PubMed ID: 27084210
[No Abstract] [Full Text] [Related]
2. Anti-neurofascin antibody in patients with combined central and peripheral demyelination.
Kawamura N; Yamasaki R; Yonekawa T; Matsushita T; Kusunoki S; Nagayama S; Fukuda Y; Ogata H; Matsuse D; Murai H; Kira J
Neurology; 2013 Aug; 81(8):714-22. PubMed ID: 23884033
[TBL] [Abstract][Full Text] [Related]
3. Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment.
Cortese A; Franciotta D; Alfonsi E; Visigalli N; Zardini E; Diamanti L; Prunetti P; Osera C; Gastaldi M; Berzero G; Pichiecchio A; Piccolo G; Lozza A; Piscosquito G; Salsano E; Ceroni M; Moglia A; Bono G; Pareyson D; Marchioni E
J Neurol Sci; 2016 Apr; 363():182-7. PubMed ID: 27000248
[TBL] [Abstract][Full Text] [Related]
4. [Neurofascin: a novel target for combined central and peripheral demyelination].
Kawamura N
Rinsho Shinkeigaku; 2014; 54(12):978-80. PubMed ID: 25672685
[TBL] [Abstract][Full Text] [Related]
5. Anti-neutral glycolipids antibody-positive combined central and peripheral demyelination mimicking encephalomyeloradiculoneuropathy phenotype.
Saito K; Toru S; Shima S; Mutoh T
Clin Neurol Neurosurg; 2018 Sep; 172():90-92. PubMed ID: 29986202
[TBL] [Abstract][Full Text] [Related]
6. Fulminant Central Plus Peripheral Nervous System Demyelination without Antibodies to Neurofascin.
Vural A; Göçmen R; Kurne AT; Oğuz KK; Temuçin ÇM; Tan E; Karabudak R; Meinl E; Erdem Özdamar S
Can J Neurol Sci; 2016 Jan; 43(1):149-56. PubMed ID: 26271726
[TBL] [Abstract][Full Text] [Related]
7. [A case of anti-neurofascin 155 antibody-positive combined central and peripheral demyelination successfully treated with plasma exchange].
Shimizu M; Koda T; Nakatsuji Y; Ogata H; Kira JI; Mochizuki H
Rinsho Shinkeigaku; 2017 Jan; 57(1):41-44. PubMed ID: 28025411
[TBL] [Abstract][Full Text] [Related]
8. Combined central and peripheral demyelination - one-year follow-up of patient with co-incidence of multiple sclerosis and multifocal acquired demyelinating sensory and motor neuropathy - A Case Report.
Marček P; Valkovič P; Minár M; Slezáková D
Neuro Endocrinol Lett; 2023 Sep; 44(6):345-350. PubMed ID: 37776551
[TBL] [Abstract][Full Text] [Related]
9. Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy.
Mendell JR; Kolkin S; Kissel JT; Weiss KL; Chakeres DW; Rammohan KW
Neurology; 1987 Aug; 37(8):1291-4. PubMed ID: 3614649
[TBL] [Abstract][Full Text] [Related]
10. The Oldest Japanese Case of Combined Central and Peripheral Demyelination, which Developed Nine Years After the First Instance of Optic Neuritis.
Nomura E; Kawahara Y; Omote Y; Tadokoro K; Takemoto M; Hishikawa N; Yamashita T; Ogata H; Abe K
Intern Med; 2021 Jan; 60(2):305-308. PubMed ID: 32921691
[TBL] [Abstract][Full Text] [Related]
11. Combined Central and Peripheral Demyelination: Two Case Reports.
Belen BG; Bülbül NG; Karsidag S; Köse E; Vural A; Özdağ F
Eur Neurol; 2024; 87(2):84-92. PubMed ID: 38325357
[TBL] [Abstract][Full Text] [Related]
12. Anti-Lactosylceramide antibody positive combined central peripheral demyelination emerging from long-standing juvenile-onset chronic inflammatory polyradiculoneuropathy; a report of two cases.
Takegami N; Sakuishi K; Yamaguchi-Takegami N; Egashira S; Komaki S; Mutoh T; Toda T
J Neuroimmunol; 2023 May; 378():578086. PubMed ID: 37079994
[TBL] [Abstract][Full Text] [Related]
13. The clinical features of combined central and peripheral demyelination and antibodies against the node of Ranvier.
Hou X; Liang Y; Cui P; Hao J
Mult Scler; 2022 Mar; 28(3):453-462. PubMed ID: 34595962
[TBL] [Abstract][Full Text] [Related]
14. The clinical features of combined central and peripheral demyelination in Chinese patients.
Wang YQ; Chen H; Zhuang WP; Li HL
J Neuroimmunol; 2018 Apr; 317():32-36. PubMed ID: 29501083
[TBL] [Abstract][Full Text] [Related]
15. A case of combined central and peripheral demyelination in Zambia.
George IC; Kvalsund M; Saylor D
Mult Scler Relat Disord; 2020 May; 40():101943. PubMed ID: 31958671
[TBL] [Abstract][Full Text] [Related]
16. Parallel fluctuation of anti-neurofascin 155 antibody levels with clinico-electrophysiological findings in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Fujita A; Ogata H; Yamasaki R; Matsushita T; Kira JI
J Neurol Sci; 2018 Jan; 384():107-112. PubMed ID: 29249367
[TBL] [Abstract][Full Text] [Related]
17. Chronic inflammatory demyelinating polyradiculoneuropathy with tumefactive central demyelination.
Krivickas LS; Hochberg FH; Freeman S
Muscle Nerve; 2006 Feb; 33(2):283-8. PubMed ID: 16086427
[TBL] [Abstract][Full Text] [Related]
18. Combined central and peripheral demyelination: A case description.
Cuenca Hernández R; Gordo Mañas R; Gredilla Molinero J
Neurologia; 2017 Oct; 32(8):547-550. PubMed ID: 26971059
[No Abstract] [Full Text] [Related]
19. Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy.
Dong C; Greathouse KM; Beacham RL; Palladino SP; Helton ES; Ubogu EE
Exp Neurol; 2017 Jun; 292():35-45. PubMed ID: 28215575
[TBL] [Abstract][Full Text] [Related]
20. Relapsing demyelinating disease affecting both the central and peripheral nervous systems.
Zéphir H; Stojkovic T; Latour P; Lacour A; de Seze J; Outteryck O; Maurage CA; Monpeurt C; Chatelet P; Ovelacq E; Vermersch P
J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1032-9. PubMed ID: 18208860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
